MycoBiomDB – Record Details (MyCo_6096)

Biomarker Record Details

Database ID: MyCo_6096
DB IDMyCo_6096
TitleTranslational proteomic study to address host protein changes during aspergillosis
Year2018
PMID30040865
Fungal Diseases involvedAspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementAll the blood specimens from penguins utilized in this work were samples banked after rou- tine veterinary assessments. Investigations in penguins were approved by the African Penguin Species Survival Plan (SSP) of the Association of Zoos & Aquariums (AZA) program and by the staff veterinarians in each of the submitting facilities.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceBlood
Host GroupAnimal
Host Common namePenguin
Host Scientific nameSpheniscidae
Biomarker NameGap junction protein
Biomarker Full NameGap junction protein
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUSA
CohortBlood samples and lung parenchyma specimens were obtained from 6–8 week-old male neutropenic rats (Rattusnorvegicus, N1 = 46).
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold Change≥ 4.0 fold
PathwayNone
Disease Introduction MechanismAspergillosis is a fungal airborne infection due to saprophytic ubiquitous molds that belong to Aspergillus genus. It is responsible for several distinct respiratory diseases in both animals and humans. For example, aspergillosis is subacute or chronic in penguins under human care in zoos, and its incidence was estimated to 20.2% in a rehabilitation center in Brazil. In such birds, it implies adaptive immunity and develops progressively at the inner surface of air sacs. In humans, the invasive form is rather encountered during severe neutropenia and is more acute; its incidence raised to 5% after intensive chemotherapy or allogenic hematopoi- etic stem-cell transplantation. Invasive aspergillosis causes high morbidity, and mortality rates have been estimated as 30–70%, depending on the underlying medical conditions, the site of infection and the degree of dissemination. The Aspergillusspecies of the Fumigati section are those which have been primarily isolated from most of the human and animal clini- cal specimens. Species belonging to Flavi, Nigrior Terrei sections have been less frequently cul- tured.
TechniqueBioinformatics analysis
Analysis MethodProteomics Analysis
ELISA kitsNone
Assay DataNone
Validation Techniques usedProteomics Analysis
Up Regulation Down RegulationDecrease
Sequence DataAccess. number (UniProt) A0A087RIK3
External LinkNone